EZSolution™ Pacritinib

A 10 mM (1 mg in 212 µl) of the potent JAK2/FLT3 inhibitor Pacritinib (SB1518) (Cat. No. 2450) in anhydrous DMSO.

Alternate Name/Synonyms: SB-1518, SB1518, 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene, Pacritinib

Appearance: Liquid

Appearance: A 10 mM solution in anhydrous DMSO

Appearance: 937272-79-2

Appearance: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₂₈H₃₂N₄O₃

Molecular Weight: 472.58

Cell-Permeable?: True

Purity: ≥98% by HPLC

Solubilities:

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: A potent JAK2/FLT3 inhibitor

MDL Number:

PubChem CID: 46216796

SMILES: C1CCN(C1)CCOC2=C3COCC=CCOCC4=CC=CC(=C4)C5=NC(=NC=C5)NC(=C3)C=C2

InChi: InChI=1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3+

InChi Key: HWXVIOGONBBTBY-ONEGZZNKSA-N

Category: Biochemicals